Augmedix, Inc. (AUGX) Tops Q1 EPS by 1c, provides guidance

Augmedix, Inc. (NASDAQ: AUGX) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $13.47 million versus the consensus estimate of $13.33 million.

GUIDANCE:

Augmedix, Inc. sees FY2024 revenue of $52-55 million, versus the consensus of $61.098 million.

For earnings history and earnings-related data on Augmedix, Inc. (AUGX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance